Etiopathogenesis of Parkinson Disease: A New Beginning?

被引:55
作者
Le, Weidong [1 ]
Chen, Shen [1 ]
Jankovic, Joseph [1 ]
机构
[1] Baylor Coll Med, Dept Neurol, Parkinsons Dis Ctr, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
transcription factors; gene regulation; dopamine neuron development; environmental neurotoxins; MESENCEPHALIC DOPAMINERGIC-NEURONS; NURR1-DEFICIENT MICE; TRANSCRIPTION FACTOR; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NERVOUS-SYSTEM; RAT MIDBRAIN; NURR1; GENE; EARLY-LIFE; IN-VITRO;
D O I
10.1177/1073858408319974
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson disease (PD) probably represents a syndrome of different disorders and origins converging into a relatively uniform neurodegenerative process. Although clinical-pathological studies have suggested that the presymptomatic phase of PD may be relatively short, perhaps less than a decade, the authors postulate that the pathogenic mechanisms may begin much earlier, possibly even in the prenatal period. Thus, some patients with PD may be born with a fewer than normal number of dopaminergic ( and nondopaminergic) neurons as a result of genetic or other abnormalities sustained during the prenatal or perinatal period; as a result of normal age-related neuronal attrition, they eventually reach the critical threshold (60% or more) of neuronal loss needed for onset of PD to become clinically manifest. The authors review the emerging evidence that genetic disruption of normal development, coupled with subsequent environmental factors ( the so called multiple-hit hypothesis), plays an important role in the etiopathogenesis of PD.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 90 条
[1]   Midbrain dopamine neuron differentiation: Factors and fates [J].
Abeliovich, Asa ;
Hammond, Rachel .
DEVELOPMENTAL BIOLOGY, 2007, 304 (02) :447-454
[2]   Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death [J].
Alavian, Kambiz N. ;
Scholz, Christian ;
Simon, Horst H. .
MOVEMENT DISORDERS, 2008, 23 (03) :319-328
[3]   Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons [J].
Albéri, L ;
Sgadó, P ;
Simon, HH .
DEVELOPMENT, 2004, 131 (13) :3229-3236
[4]  
Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]
[5]   Adapting proteostasis for disease intervention [J].
Balch, William E. ;
Morimoto, Richard I. ;
Dillin, Andrew ;
Kelly, Jeffery W. .
SCIENCE, 2008, 319 (5865) :916-919
[6]   A fetal risk factor for Parkinson's disease [J].
Barlow, BK ;
Richfield, EK ;
Cory-Slechta, DA ;
Thiruchelvam, M .
DEVELOPMENTAL NEUROSCIENCE, 2004, 26 (01) :11-23
[7]   The gestational environment and Parkinson's disease: Evidence for neurodevelopmental origins of a neurodegenerative disorder [J].
Barlow, Brian K. ;
Cory-Slechta, Deborah A. ;
Richfield, Eric K. ;
Thiruchelvam, Mona .
REPRODUCTIVE TOXICOLOGY, 2007, 23 (03) :457-470
[8]  
BERGMAN O, 2008, NEUROBIOL AGING
[9]   A null mutation in TGF-α leads to a reduction in midbrain dopaminergic neurons in the substantia nigra [J].
Blum, H .
NATURE NEUROSCIENCE, 1998, 1 (05) :374-377
[10]   Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors [J].
Bonilla, Sonia ;
Hall, Anita C. ;
Pinto, Luisa ;
Attardo, Alessio ;
Goetz, Magdalena ;
Huttner, Wieland B. ;
Arenas, Ernest .
GLIA, 2008, 56 (08) :809-820